https://jmj.jums.ac.ir/ Pars Journal of Medical Sciences en daily 1 Fri, 22 May 2026 00:00:00 +0330 Fri, 22 May 2026 00:00:00 +0330 https://jmj.jums.ac.ir/article_737297.html Background: Dialysis patients are at high risk of hepatitis B virus (HBV) infection due to shared dialysis machines. This study aimed to determine the association of immunity to HBV with serum levels of liver function markers in dialysis patients vaccinated against HBV.Methods: This cross-sectional-analytical study was conducted on 64 dialysis patients in Jahrom-Iran, 2025. Demographic information, serum levels of antibodies against HBV, and liver function indexes were extracted from the patients' records. After collection, the data were analyzed using SPSS-16 software and descriptive and analytical statistics.Results: Of the 64 dialysis patients studied, 59.4% were male. 87.50% of patients were immune to HBV. There was no significant difference in terms of age, gender, and HBV immunity status (P >0.05). The mean serum levels of transferases, alkaline phosphatase, and bilirubin were statistically significantly different in immune and non-immune patients (P <0.05).Conclusion: The immunity rate to HBV in the studied patients is satisfactory compared to the results of other studies. This immunity has a significant inverse relationship with the serum levels of transferases, alkaline phosphatase and bilirubin. It is recommended to conduct detailed studies with a larger sample size to investigate the role of these factors and liver diseases on immunity to HBV in dialysis patients. https://jmj.jums.ac.ir/article_737401.html Introduction: The mammalian cell cycle is a highly conserved process and contains four distinct ordered phases. There are multiple checkpoint mechanisms to protect genome integrity. Deregulations in these checkpoint mechanisms promote cancer induction. Downregulation of tumor suppressor genes (TSGs) because of DNA methylation and histone deacetylation result in cancer induction. Fortunately, this process is reversible and re-expression of TSGs induce apoptosis induction. In this review, positive and negative cell cycle regulators and therapeutic strategies are investigated.Methods: This narrative review study has been written with investigation of a series of articles published in the field of cancer. In this work, several keywords were selected from MESH including Cyclin, Cyclin-dependent kinase, cyclin-dependent kinase inhibitors, Tumor suppressor genes, DNA methyltransferase, and Histone deacetylase and search was done using the PubMed online database and the Scholar website. Finally, good and high- quality studies were investigated.Results: Re-expression of TSGs by epigenetic drugs is suitable strategy for cancer treatment. These compounds can inhibit DNMTs and HDACs activities resulting in re-expression of TSGs.Conclusion: Epigenetic drugs can reactivate silenced TSGs, resulting in apoptosis induction. This method can be a good strategy for cancer treatment.